Mainz Biomed Secures Additional $1.5M Funding
Company Announcements

Mainz Biomed Secures Additional $1.5M Funding

Mainz Biomed B.V. (MYNZ) has released an update.

Mainz Biomed B.V. has entered into a supplemental agreement with YA II PN, LTD. for a fourth Pre-Paid Advance of $1.5 million, following three previous promissory notes totaling $14.3 million. The funds from this latest note are designated for working capital and general corporate purposes, ensuring the company’s continued operations without shareholder approval for issuance. The transaction is exempt from registration under the Securities Act, indicating a private placement strategy.

For further insights into MYNZ stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskMainz Biomed Partners with Thermo Fisher for Cancer Screening
TheFlyMainz Biomed, Thermo Fisher sign collaboration agreement
TheFlyMainz Biomed files to sell 30.77M ordinary shares
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App